Pelthos Therapeutics Inc. Files 8-K on Executive Changes
Ticker: PTHS · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1919246
| Field | Detail |
|---|---|
| Company | Pelthos Therapeutics Inc. (PTHS) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-composition, governance
TL;DR
Pelthos Inc. 8-K filed 12/23/25: Exec changes, director elections, officer appointments, and compensation details.
AI Summary
Pelthos Therapeutics Inc. filed an 8-K on December 23, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also covers other events and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in executive and director positions can signal internal shifts or strategic realignments that may carry inherent business risks.
Key Players & Entities
- Pelthos Therapeutics Inc. (company) — Registrant
- December 23, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
FAQ
Who specifically departed from their roles at Pelthos Therapeutics Inc.?
The filing indicates the 'Departure of Directors or Certain Officers' as an item reported, but does not name the individuals in the provided text.
Were any new directors or officers appointed?
Yes, the filing explicitly lists 'Election of Directors' and 'Appointment of Certain Officers' as reported items.
What is the nature of the 'Compensatory Arrangements' mentioned?
The filing states 'Compensatory Arrangements of Certain Officers' are being reported, but the specific details of these arrangements are not provided in the excerpt.
What other events are being reported in this 8-K?
The filing also covers 'Other Events' in addition to the executive and director changes.
When was Pelthos Therapeutics Inc. incorporated?
Pelthos Therapeutics Inc. was incorporated in Nevada.
Filing Stats: 1,126 words · 5 min read · ~4 pages · Grade level 11.5 · Accepted 2025-12-23 17:30:32
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PTHS The NYSE American LL
Filing Documents
- g085052_8k.htm (8-K) — 39KB
- g085052_ex99-1.htm (EX-99.1) — 14KB
- image_001.jpg (GRAPHIC) — 2KB
- 0001753926-25-001964.txt ( ) — 226KB
- pths-20251223.xsd (EX-101.SCH) — 3KB
- pths-20251223_lab.xml (EX-101.LAB) — 33KB
- pths-20251223_pre.xml (EX-101.PRE) — 22KB
- g085052_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 23, 2025 Pelthos Therapeutics Inc. By: /s/ Francis Knuettel II Name: Francis Knuettel II Title: Chief Financial Officer